Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 18/20 | 0.76 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.76 |
| ▸ | NPY4R | P50391 | 2/20 | 0.67 |
| ▸ | NPFFR1 | Q9GZQ6 | 2/20 | 0.66 |
| ▸ | NPFFR2 | Q9Y5X5 | 2/20 | 0.66 |
| ▸ | NPY2R | P49146 | 2/20 | 0.63 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28882485 | 0.81 | NPY1R (1.00) | NPY1RNPY5RNPY4RNPFFR1NPFFR2 | |
| SCHEMBL29440093 | 0.80 | NPY1R (1.00) | NPY1RNPY5RNPY4RNPFFR1NPFFR2 | |
| SCHEMBL29416820 | 0.79 | NPY1R (1.00) | NPY1RNPY5RNPY4RNPFFR1NPFFR2 | |
| Trifluoroacetic Acid SCHEMBL29430275 | 0.75 | NPY1R (0.89) | NPY1RNPY5RNPY4RNPFFR1NPFFR2 | |
| Trifluoroacetic Acid SCHEMBL30887954 | 0.75 | NPY1R (0.89) | NPY1RNPY5RNPY4RNPFFR1NPFFR2 | |
| SCHEMBL8526459 | 0.73 | NPY1R (0.54) | NPY1RNPY5RNPY4RNPFFR1NPFFR2 | |
| SCHEMBL8120862 | 0.73 | NPY1R (0.54) | NPY1RNPY5RNPY4RNPFFR1NPFFR2 | |
| SCHEMBL5317762 | 0.72 | NPY1R (0.53) | NPY1RNPY5RNPY4RNPFFR1NPFFR2 | |
| SCHEMBL29351314 | 0.72 | MC4R (0.65) | NPY1RNPY5RNPY4RNPY2R | |
| SCHEMBL29393341 | 0.70 | SIRT5 (0.64) | NPY1RNPY5RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115286625-B | Glutaminase allosteric site covalent inhibitor and preparation method and application thereof | 浙江工业大学 | 2025-03-25 | — | — | CN | claimed |
| CN-115286625-B | Glutaminase allosteric site covalent inhibitor and preparation method and application thereof | 浙江工业大学 | 2025-03-25 | — | — | CN | disclosed |
| EP-3450444-B1 | CROCINS COMPOUNDS AND USES THEREOF | UNIV JINAN (CN) | 2023-11-15 | — | — | EP | disclosed |
| US-11661523-B2 | Ink, ink accommodating unit, recording method, recording device, and method of manufacturing ink | RICOH COMPANY, LTD. (JP) | 2023-05-30 | — | — | US | disclosed |
| CN-115286625-A | Glutaminase allosteric site covalent inhibitor and preparation method and application thereof | 浙江工业大学 | 2022-11-04 | — | — | CN | disclosed |
| US-11440931-B2 | Crocins compounds and uses thereof | JINAN UNIVERSITY (CN) | 2022-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11440931-B2 | Crocins compounds and uses thereof | GRIN1, GRIK4, CROCC | NPY1R 1363/4885NPY5R 1537/4885NPY4R 1148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.